- Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
- Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
- Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
- Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
- Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Bicycle Therapeutics to Present at the AACR Annual Meeting 2024
More ▼
Key statistics
On Friday, Bicycle Therapeutics PLC (BCYC:NSQ) closed at 22.19, -23.24% below its 52-week high of 28.91, set on Jun 20, 2023.
52-week range
Open | 22.02 |
---|---|
High | 24.00 |
Low | 21.83 |
Bid | 21.62 |
Offer | 23.19 |
Previous close | 21.92 |
Average volume | 489.70k |
---|---|
Shares outstanding | 68.71m |
Free float | 30.27m |
P/E (TTM) | -- |
Market cap | 1.52bn USD |
EPS (TTM) | -4.45 USD |
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼